Dilated cardiomyopathy - guidelines for personalization of care

Dilated cardiomyopathy - guidelines for personalization of care

The term dilated cardiomyopathy (DCM) refers to a family of diseases characterized by complex interactions between environment and genetic predisposition. Diagnostic tools such as cardiac magnetic resonance imaging should be systematically implemented in clinical practice to define the etiological...

Full description

Saved in:

Bibliographic Details
Main Authors:	Antonella Spinelli, Gaetano Marino, Alfredo Macchiusi, Stefania Angela Di Fusco, Carlo Pignalberi, Furio Colivicchi
Format:	Article
Language:	English
Published:	PAGEPress Publications 2025-04-01
Series:	Monaldi Archives for Chest Disease
Subjects:	Heart failure subcutaneous defibrillator
Online Access:	https://www.monaldi-archives.org/macd/article/view/3173
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
by: Yuki Konno, et al.
Published: (2025-04-01)

Real-World Efficacy and Safety of the Subcutaneous Implantable Cardioverter Defibrillator: Insights from the GASP Registry
by: Nikias Milaras, et al.
Published: (2025-06-01)

Cardiomyopathies and Arrythmias in Neuromuscular Diseases
by: Giuseppe Sgarito, et al.
Published: (2025-03-01)

THE SIGNIFICANCE OF FUNCTIONAL AND ETIOLOGICAL DIAGNOSTIC FOR TREATMENT STRATEGY DECISION IN PATIENTS WITH DILATED CARDIOMYOPATHY
by: Yu. V. Frolova
Published: (2014-05-01)

Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems
by: A. V. Vereshchagina, et al.
Published: (2022-09-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

Contemporary Management of Patients With Chagas Cardiomyopathy in Bolivia
by: Evan Czulada, BS, et al.
Published: (2025-03-01)

CRO-INSIGHT: Utilization of Implantable Cardioverter Defibrillators in Non-ischemic and Ischemic Cardiomyopathy in a Single Croatian Tertiary Hospital Centre
by: Mislav Puljevic, et al.
Published: (2025-04-01)

Radiomic Cardiac MRI Signatures for Predicting Ventricular Arrhythmias in Patients With Nonischemic Dilated Cardiomyopathy
by: Amine Amyar, PhD, et al.
Published: (2025-04-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01)

Clinical outcomes during and after wearable cardioverter defibrillator use in Japanese patients with heart failure: A single‐center experience
by: Noriko Kikuchi, et al.
Published: (2024-12-01)

Heart Transplantation as a Treatment Method for Refractory Heart Failure due to Post-myocarditis Dilated Cardiomyopathy: a Clinical Case
by: Larisa A. Balykova, et al.
Published: (2019-06-01)

2014 ESC GUIDELINES ON DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY
by: Perry M. Elliott, et al.
Published: (2015-05-01)

Validation of ACC/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study
by: Murillo Oliveira Antunes, et al.
Published: (2024-12-01)

Modern View on the Dilated Cardiomyopathy
by: Yuzych I.
Published: (2014-06-01)

ACTUAL SURGICAL TREATMENT OF DILATED CARDIOMYOPATHY
by: D. V. Shumakov, et al.
Published: (2009-06-01)

Incidence of Rapid Rate Non‐Sustained and Sustained Ventricular Tachycardia in Implantable Cardioverter‐Defibrillator Recipients and Its Correlation With Heart Failure Guideline‐Directed Medical Therapy Compliance
by: Muhammad Taha Khan, et al.
Published: (2025-08-01)

Comparative analysis of implantable cardioverter-defibrillator efficacy in ischemic and non-ischemic cardiomyopathy in patients with heart failure
by: Emre Demir, et al.
Published: (2025-07-01)

Twiddler's syndrome: The slow twist of a pruritic pacemaker
by: Fiona E. Gallahue, et al.
Published: (2020-08-01)

Factors associated with the risk of progression and decompensation of heart failure in patients with an implantable cardioverter-defibrillator
by: N. B. Lebedeva, et al.
Published: (2024-04-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Personalized care in dilated cardiomyopathy: Rationale and study design of the activeDCM trial
by: Farbod Sedaghat‐Hamedani, et al.
Published: (2024-12-01)

Methylations in dilated cardiomyopathy and heart failure
by: Cong Qin, et al.
Published: (2025-04-01)

Comparative Diagnostic Efficacy of HeartLogic and TriageHF Algorithms in Remote Monitoring of Heart Failure: A Cohort Study
by: David Ledesma Oloriz, et al.
Published: (2025-05-01)

Embodied Revelation:
by: Vera Barton-Caro
Published: (2015-12-01)

CONTROL TECHNOLOGY ENERGY DISCHARGE OF A DEFIBRILLATOR
by: E. E. Gorokhov-Miroshnikov, et al.
Published: (2022-08-01)

Thyroid status and levothyroxine natrium effectiveness in patients with dilated cardiomyopathy
by: T. A. Abdullaev, et al.
Published: (2010-06-01)

Midkine Serum Levels in Inflammatory and Non-Inflammatory Dilated Cardiomyopathy
by: Ulrich Grabmaier, et al.
Published: (2025-02-01)

Outcome and prognostic value of N‐terminal pro‐brain natriuretic peptide and high‐sensitivity C‐reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy
by: Jiayu Feng, et al.
Published: (2022-06-01)

The impact of locked cabinets for automated external defibrillators (AEDs) on cardiac arrest and AED outcomes: A scoping review
by: Lawrence Oonyu, et al.
Published: (2024-12-01)

LAMIN A/C GENE (LMNA) MUTATIONS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND THEIR PHENOTYPIC MANIFESTATION
by: T. G. Vaikhanskaya, et al.
Published: (2016-03-01)

External validation of a multivariate model for predicting the risk of death in patients with chronic heart failure and an implantable cardioverter – defibrillator
by: N. B. Lebedeva, et al.
Published: (2024-07-01)

Digitalis Therapy Is Associated With an Increased Risk of ICD Shock Delivery and Device Revision
by: Gerrit Frommeyer, et al.
Published: (2025-05-01)

Co-existence of RBM20 and KCNQ1 gene mutations in a patient with long QT syndrome and dilated cardiomyopathy. “Which came first: Chicken or the egg?”
by: Jithin S. Panicker, et al.
Published: (2025-05-01)

Extensive subcutaneous emphysema treated with subcutaneous angiocatheters
by: Lena Carleton, et al.
Published: (2023-10-01)

A Rare Case of Dilated Cardiomyopathy in Sjögren’s Syndrome
by: Pradnya Diggikar, et al.
Published: (2024-12-01)

Utility of Neutrophil-To-Lymphocyte Ratio as Prognostic Marker of Dilated Cardiomyopathy in Children
by: Sadaf Liaqat, et al.
Published: (2025-04-01)

Heart transplantation in secondary dilated cardiomyopathy due to myocarditis. Case report
by: D. V. Romashova, et al.
Published: (2023-06-01)

Novel Acquisitions and Supporting Evidence in Pathophysiology of Stress-Induced Cardiomyopathy: A Narrative Review
by: Andrea Matteucci, et al.
Published: (2025-05-01)

Implantable cardioverter defibrillator: decision-making on turning off in patients with end-stage heart failure
by: V. K. Lebedeva, et al.
Published: (2020-09-01)